Skip to Content

Clinical Trial Detail

CALGB 30607

Patient Information

Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511, IND #74019) as Maintenance Therapy in Non-Progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer 

Study Number
CALGB 30607

Clinical Trial Categories

  • Lung Cancer - Metastatic

Location

  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725

Directions

Directions: If entering campus from Huffman Mill Road then go straight until you come to a stop sign. At the stop sign go straight. Take your first right after the stop sign to enter Cancer Center parking lot. If you enter the hospital campus from Grand Oaks Boulevard then turn left after entering and take your first right into the Cancer Center parking lot. Once you enter the Cancer Center, go down the hallway on your right and the Large Conference Room is at the end of the hallway.

Also in this Section